Skip to main content
. Author manuscript; available in PMC: 2015 Jan 1.
Published in final edited form as: J Subst Abuse Treat. 2013 Sep 12;46(1):10.1016/j.jsat.2013.08.009. doi: 10.1016/j.jsat.2013.08.009

Table 1.

Baseline Characteristics of Study Participants (n = 59)

Variable eGetgoing
(n=24)		 In-person
(n=35)		 p
M (SD) or % M (SD) or %
Demographics
 Female (%) 54.2 57.1 ns
 Married (%) 33.3 31.4 ns
 Age (yrs) 40.5 (11.15) 41.1 (10.50) ns
 Education (yrs) 12.3 (2.39) 11.9 (1.85) ns
 Minority (%) 25.0 42.9 ns
 Full time employed (%) 58.3 37.1 ns
Treatment variables in 3 months prior to study consent
 Urine tests positive for drug use (%) 7.3 5.7 ns
 Submit monthly vs. weekly urine screens (%) 62.5 54.3 ns
 Length of treatment prior to consent (days) 2052 (1926) 1242 (1555) 0.080
 Number weekly methadone take-home doses 4.3 (2.48) 3.5 (1.74) ns